ASCO 2024 abstracts released—Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial —Bicycle Therapeutics scores $555M investment for disease prevention --http://bit.ly/w28kSd #asco2024 #asco #ozempic #kidneydisease #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma